Natixis Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.88M | Buy |
|
|||||
|
2024
Q4 | $2.87M | Sell |
|
|||||
|
2024
Q3 | $8.77M | Buy |
|
|||||
|
2024
Q2 | $6.74M | Buy |
|
|||||
|
2024
Q1 | $5.08M | Buy |
|
|||||
|
2023
Q4 | $3.64M | Buy |
|
|||||
|
2023
Q3 | $2.12M | Sell |
|
|||||
|
2023
Q2 | $3.21M | Buy |
|
|||||
|
2023
Q1 | $2.53M | Buy |
|
|||||
|
2022
Q4 | $843K | Buy |
|
|||||
|
2022
Q3 | $1M | Buy |
|
|||||
|
2022
Q2 | $322K | Buy |
|
|||||
|
2022
Q1 | $372K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.82M | Buy |
|
|||||
|
2017
Q1 | $1.82M | Buy |
|
|||||
|
2016
Q4 | $1.48M | Sell |
|
|||||
|
2016
Q3 | $1.87M | Buy |
|
|||||
|
2016
Q2 | $2.59M | Buy |
|
|||||
|
2016
Q1 | $2.42M | Buy |
|
|||||
|
2015
Q4 | $1.13M | Buy |
|
|||||
|
2015
Q3 | $681K | Buy |
|
|||||
|
2015
Q2 | $549K | Buy |
|
|||||
|
2015
Q1 | $565K | Buy |
|
|||||
|
2014
Q4 | $484K | Buy |
|
|||||
|
2014
Q3 | $541K | Buy |
|
|||||
|
2014
Q2 | $487K | Sell |
|
|||||
|
2014
Q1 | $520K | Sell |
|
|||||
|
2013
Q4 | $1.24M | Buy |
|
|||||
|
2013
Q3 | $1.14M | Buy |
|
|||||
|
2013
Q2 | $1.17M | Buy |
|